Compare Integrated Diagnostics Holdings Plc with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
79.75%
0%
79.75%
6 Months
30.28%
0%
30.28%
1 Year
75.31%
0%
75.31%
2 Years
53.1%
0%
53.1%
3 Years
-43.48%
0%
-43.48%
4 Years
-49.73%
0%
-49.73%
5 Years
-42.56%
0%
-42.56%
Integrated Diagnostics Holdings Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-28.57%
EBIT Growth (5y)
-35.43%
EBIT to Interest (avg)
7.26
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.46
Sales to Capital Employed (avg)
2.04
Tax Ratio
32.26%
Dividend Payout Ratio
19.27%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
111.04%
ROE (avg)
25.77%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
4.66
EV to EBIT
9.91
EV to EBITDA
7.62
EV to Capital Employed
7.41
EV to Sales
2.33
PEG Ratio
1.09
Dividend Yield
3.63%
ROCE (Latest)
74.72%
ROE (Latest)
29.19%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Jun 2022
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.03%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'24 - YoY
Sep'24
Sep'23
Change(%)
Net Sales
33.20
38.20
-13.09%
Operating Profit (PBDIT) excl Other Income
13.30
12.60
5.56%
Interest
0.00
1.30
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5.00
5.70
-12.28%
Operating Profit Margin (Excl OI)
401.50%
246.70%
15.48%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2024 is -13.09% vs -13.57% in Sep 2023
Consolidated Net Profit
YoY Growth in quarter ended Sep 2024 is -12.28% vs 400.00% in Sep 2023
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
159.50
126.10
26.49%
Operating Profit (PBDIT) excl Other Income
53.70
36.40
47.53%
Interest
5.50
4.30
27.91%
Exceptional Items
-0.20
-0.70
71.43%
Consolidate Net Profit
26.40
22.20
18.92%
Operating Profit Margin (Excl OI)
264.80%
203.90%
6.09%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 26.49% vs -6.04% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 18.92% vs 45.10% in Dec 2024
About Integrated Diagnostics Holdings Plc 
Integrated Diagnostics Holdings Plc
Hospital
Integrated Diagnostics Holdings plc is an integrated diagnostics services provider in Egypt. The Company operates in three geographic areas: Egypt, Sudan and Jordan. The Company provides over 1,000 diagnostic services ranging from basic tests to molecular tests for hepatitis and specialized deoxyribonucleic acid (DNA) tests to patients, and operates approximately 310 branches. The Company offers a range of services, such as Immunology, Radiology, Hematology, Endocrinology, Molecular Biology, Cytogenetics, Hatopathology and Microbiology. The Company's core brands include Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan, and Ultralab and Al Mokhtabar Sudan in Sudan. The Company also operates the Medical Genetics Centre brand in Egypt. Its Al Mokhtabar medical testing and diagnostic center provides services, including radiological tests, a center for allergy, a unit for nutritional advice, pre-employments tests, medical examination in different fields and checkup packages.
Company Coordinates 
Company Details
12 Castle Street , SAINT HELIER None : JE2 3RT
Registrar Details






